重组Anti-TNFAIP3抗体[EPR2663]
Anti-TNFAIP3 antibody [EPR2663]
- KO Validated
- RabMAb
- Recombinant
- 了解详情
5
(1 Review)
|
(50 Publications)
Anti-TNFAIP3 antibody [EPR2663] (ab92324) is a rabbit monoclonal antibody detecting TNFAIP3 in Western Blot, IHC-P. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
- Trusted since 2010
查看别名
OTUD7C, TNFAIP3, Tumor necrosis factor alpha-induced protein 3, TNF alpha-induced protein 3, OTU domain-containing protein 7C, Putative DNA-binding protein A20, Zinc finger protein A20
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling TNFAIP3 with unpurified ab92324 at 1/50. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. A prediluted HRP-polymer conjugated anti-rabbit IgG was used as the secondary antibody. Counterstained with Hematoxylin.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling TNFAIP3 with purified ab92324 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. A prediluted HRP-polymer conjugated anti-rabbit IgG was used as the secondary antibody. Counterstained with Hematoxylin.
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Western blot : Anti-TNFAIP3 antibody [EPR2663] (ab92324) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab92324 was shown to bind specifically to TNFAIP3. A band was observed at 90 kDa in wild-type U-87 MG cell lysates with no signal observed at this size in TNFAIP3 knockout cell line. To generate this image, wild-type and TNFAIP3 knockout U-87 MG cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Wild-type U-87 MG cell lysate at 20 µg
Lane 2:
TNFAIP3 knockout U-87 MG cell lysate at 20 µg
Lane 3:
Wild-type A549 cell lysate at 20 µg
Lane 4:
TNFAIP3 knockout A549 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
false
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Lanes 1-4 : Merged signal (red and green). Green - ab92324 observed at 80 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab92324 Anti-TNFAIP3 antibody [EPR2663] was shown to specifically react with TNFAIP3 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265983 (knockout cell lysate ab257112) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
TNFAIP3 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human TNFAIP3 knockout HeLa cell line (<a href='/products/cell-lines/human-tnfaip3-knockout-hela-cell-line-ab265983'>ab265983</a>)
Lane 3:
Jurkat cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate at 20 µg
Lane 4:
Untreated Jurkat cell lysate at 20 µg
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/3000 dilution
All lanes:
Jurkat cell lysate - treated with TNF (<a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) and TPA at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
- WB
Supplier Data
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Lanes 1-4 : Merged signal (red and green). Green - ab92324 observed at 80 kDa. Red - loading control ab8245 observed at 36 kDa.
ab92324 Anti-TNFAIP3 antibody [EPR2663] was shown to specifically react with TNFAIP3 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab266945 (knockout cell lysate ab257113) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
TNFAIP3 knockout A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human TNFAIP3 knockout A549 cell line (<a href='/products/cell-lines/human-tnfaip3-knockout-a549-cell-line-ab266945'>ab266945</a>)
Lane 3:
Jurkat (Human T cell leukemia cell line from peripheral blood) cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate at 20 µg
Lane 4:
Untreated Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Jurkat cells treated with TNF (<a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) and TPA at 10 µg
Lane 2:
Daudi cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 89 kDa
false
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Lanes 1- 4 : Merged signal (red and green). Green - ab92324 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab92324 was shown to react with TNFAIP3 in wild-type A549 cells in western blot. Loss of signal was observed when knockout cell line ab266946 (knockout cell lysate ab257114) was used. Wild-type A549 and TNFAIP3 knockout A549 cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
TNFAIP3 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human TNFAIP3 knockout A549 cell line (<a href='/products/cell-lines/human-tnfaip3-knockout-a549-cell-line-ab266946'>ab266946</a>)
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
TNFAIP3 knockout HeLa cell lysate at 20 µg
Predicted band size: 89 kDa
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/2000 dilution
All lanes:
Jurkat cell lysate - treated with TNF (<a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) and TPA at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
Lanes 1-4 : Merged signal (red and green). Green - ab92324 observed at 80 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab92324 Anti-TNFAIP3 antibody [EPR2663] was shown to specifically react with TNFAIP3 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265983 (knockout cell lysate ab257112) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
TNFAIP3 knockout HeLa cell lysate at 20 µg
Lane 3:
Jurkat cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate at 20 µg
Lane 4:
Untreated Jurkat cell lysate at 20 µg
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
- WB
Lab
Western blot - Anti-TNFAIP3 antibody [EPR2663] (AB92324)
All lanes:
Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/5000 dilution
Lane 1:
WEHI-3 (Mouse leukemia lymphoblast) whole cell lysate at 20 µg
Lane 2:
WEHI-3 treated with 20 ng/ml TNF alpha (<a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) for 6 h at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 89 kDa
Observed band size: 80 kDa
false
不同偶联物与剂型 (8)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-TNFAIP3 antibody [EPR2663]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-TNFAIP3 antibody [EPR2663]
-
Anti-TNFAIP3 antibody [EPR2663] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-TNFAIP3 antibody [EPR2663]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-TNFAIP3 antibody [EPR2663]
-
HRP Anti-TNFAIP3 antibody [EPR2663]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-TNFAIP3 antibody [EPR2663]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-TNFAIP3 antibody [EPR2663]
反应性数据
产品详情
What is this antibody validated in?
Anti-TNFAIP3 antibody [EPR2663] (ab92324) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, Mouse samples.
What is the molecular weight of TNFAIP3?
Anti-TNFAIP3 [EPR2663] (ab92324) specifically detects a band for TNFAIP3 (UniProt: P21580) at a molecular weight of 90kDa.
Trusted by the scientific community
Anti-TNFAIP3 [EPR2663] (ab92324) was first used in a scientific publication in 2010 and has been cited over 30 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-TNFAIP3 antibody [EPR2663] (ab92324) has been confirmed by Western blot testing in TNFAIP3 Knockout HeLa cell line, ab265983.
Other related products
We have a range of other formats of antibody clone [EPR2663] also available for your convenience: ab92324, Alexa Fluor® 647 - ab197068, Alexa Fluor® 488 - ab197541, Carrier free - ab227987, HRP - ab305736, Alkaline Phosphatase - ab308916, Alexa Fluor® 594 - ab310642, Alexa Fluor® 555 - ab312172, Alexa Fluor® 568 - ab312659, Alexa Fluor® 750 - ab321747
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (50)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1553 PubMed41073958
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:28976 PubMed40775512
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40430063
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 21:e1012467 PubMed40198713
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of surgical oncology 23:71 PubMed40025550
2025
Applications
Unspecified application
Species
Unspecified reactive species
International ophthalmology 44:437 PubMed39578251
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of clinical and experimental urology 12:64-87 PubMed38736619
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 42:238-252.e9 PubMed38215749
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 20:464-485 PubMed38169584
2024
Applications
Unspecified application
Species
Unspecified reactive species
Archives of gerontology and geriatrics 117:105274 PubMed37995648
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com